Slide 1: Introduction to Evogene
Introduction to Evogene March, 2015 Ofer Haviv, President & CEO
Slide 2: Safe Harbor Statement
Safe Harbor Statement This presentation contains "forward-looking statements" relating to future events, and we may from time to time make other statements, regarding our outlook or expectations for future financial or operating results and/or other matters regarding or affecting Evogene Ltd. or its
Slide 3: Evogene at a glance
Our mission ¢ Leader in the improvement of crop productivity and economics for the food, feed and biofuel industries Products and end- markets ¢ Seed traits : improve traits underlying crops performance through biotechnology or breeding — Yield improvement: $5 - $7 billion market — Insect and diseas
Slide 4: Introducing Evogene
Introducing Evogene Who we are A leading genomics company for the improvement of crop productivity and economics addressing the increasing demand for food, feed and biofuel
Slide 5: The challenge and opportunity
The challenge: producing more with less The solution: increasing plant productivity and performance The opportunity: utilizing genomics to improve plant productivity The challenge and opportunity World population (in billions) I Source: United States Census Bureau. Hectares per capita, globally I So
Slide 6: Technology and competitive position
Technology and competitive position Our technology Combining deep scientific understandings of genomics and proprietary computational capabilities , to leverage agriculture related big data’ for prediction and validation of new products
Slide 7: Our unique position - solving the industry bottleneck
Agriculture is becoming heavily digitized creating a tremendous opportunity for innovation-based products ] Introduction to Evogene Our unique position - solving the industry bottleneck Costs Sources Diversity Quantity Complexity
Slide 8: Our technology platform
Public Proprietary Partner ‘Big data’ Integrated database Output ] Introduction to Evogene Data Integration OMIC data analysis Gene centric (Plant & Microbial) Microbial centric Chemical Centric Breeding enhancement Microbial Discovery Optimize gene efficacy Identify novel genes Identify novel targe
Slide 9: Target markets and offering
] Introduction to Evogene Target markets and offering Target markets 1 . Improved seed traits: - biotech seeds (~$20bn) and conventional seeds (~$19bn) 2. Seed external: - ag-chemicals (~$54bn) 3. Proprietary seeds (Evofuel): - castor for industry uses ($600m) and as second generation feedstock for
Slide 10: Strategic position in plant genomics
Unique technology platform combining expertise in plant science and cutting edge computational skills Seed traits Seed external Seeds Strategic position in plant genomics Yield and abiotic stress • Yield • Drought tolerance • Fertilizer utilization Biotic stress • Plant disease • Nematode resistance
Slide 11: Seed traits - yield & abiotic stress: current product program pipeline
Potential near-term catalysts as more genes advance to Phase 2 Corn 1. Yield 2. Abiotic stress 3. Nitrogen use efficiency Soybean 4. Yield 5. Abiotic stress 6. Yield 7. Abiotic stress 8. Nitrogen use efficiency Cotton 9. Yield 10. Abiotic stress 11. Nitrogen use efficiency 12. Yield 13. Abiotic stre
Slide 12: Example - collaboration with Monsanto
Gene discovery and trait optimization by Evogene Development and commercialization by Monsanto Example - collaboration with Monsanto Focus on yield and abiotic stress - Aug. 2008, extended Nov. 2011 and Oct. 2013 ¢ 8 Year collaboration ¢ Traits - yield, drought tolerance, fertilizer utilization ¢ Bi
Slide 13: Seed traits - biotic stress: current product program pipeline
Corn 1. Fusarium 2. Rootworm 3. Lygus hesperus Soybean 4. Asian Rust 5. Nematode 6. Aphids Banana 7. Black Sigatoka Cotton 8. Beet Armyworm Crop Trait Partner 2. Seed traits - biotic stress Current product program pipeline Note: Any results, estimates, or calculations relating to probability of succ
Slide 14: Seed external - agriculture chemicals
Unique approach: biology to drive herbicide discovery Ag-chemicals : robust market ] Introduction to Evogene ¢ Activities initiation - 2012 ¡ On-going internal program - ¡ Target discovery & validation, initial hits ¢ Facilities, technology, personnel ¢ Seeking collaboration - major ag-player Chemis
Slide 15: Our proposition: targeting three multi-billion dollar markets
Yield & Abiotic Stress Traits Insect Resistance & Disease Traits Herbicides Our proposition Targeting three multi-billion dollar markets $5B - $7B Market Opportunity Path to Market Unique technology platform Cutting edge Expertise in plant science Infrastructure § Initiation - 2002 § Strategic, broa
Slide 16: Strategic position in plant genomics
Unique technology platform combining expertise in plant science and cutting edge computational skills Seed traits Seed external Seeds Strategic position in plant genomics Yield and abiotic stress • Yield • Drought tolerance • Fertilizer utilization Biotic stress • Plant disease • Nematode resistance
Slide 17: Seeds (castor): huge market potential
Huge market potential Commercial production expected in 2016 ] Introduction to Evogene Short term use: ¢ Existing industries: biopolymers, lubricants, paints, etc. Long term use: ¢ Second generation feedstock for biodiesel ¢ Activities initiated in 2007 ¢ Established in 2012 as a wholly owned subsid
Slide 18: Business model & partners
] Introduction to Evogene Core revenue model and partnerships Business model & partners • Initial revenues : R&D and milestone payments from partners; castor seed sales • Primary long-term revenues: royalties from seed traits and ag-chemicals • Collaborations with world leading agriculture companies
Slide 19: Our core revenue model
• Revenue from direct castor bean seed sales anticipated from 2016 onwards • R&D payments paid by partner in the majority of our collaborations • Additional payments received upon achieving predetermined objectives • Potential royalties vary on average between 5%-12% of future trait sales M M M M Se
Slide 20: Corporate Identity and Cash position
Corporate Identity Cash position (December 31, 2014) Corporate information (1) As of February 10, 2015 ¡ Key milestones: § 2002 - Spins off from Compugen (NASDAQ:CGN) § 2007 - lists on TASE (EVGN) ~$34m (gross proceeds) § 2013 - lists on NYSE (EVGN) ~$85m (gross proceeds ¡ Market cap ~$260m , ¡ shar
Slide 21: Evogene Plant Innovation
evogene Plant Innovation